封面
市場調查報告書
商品編碼
1726356

心臟工作站市場規模、佔有率、趨勢分析報告:按應用、分銷管道、地區、細分市場預測,2025-2030 年

Cardiac Workstation Market Size, Share & Trends Analysis Report By End-use (Hospitals, Ambulatory Surgery Centers), By Distribution Channel (Medical Surge Distribution, IT/CDW/VAR-value Added Reseller), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

心臟工作站市場規模與趨勢

預計 2024 年全球心臟工作站市場規模將達到 3.6326 億美元,2025 年至 2030 年的複合年成長率為 9.10%。

心臟工作站市場的發展受到心血管疾病患病率上升、心電圖 (ECG) 檢查增多以及易患心臟病的老年人口增加的推動。根據牛津大學出版社 2024 年 11 月發布的數據,全球每年進行的心電圖檢查超過 3 億次。

心血管疾病盛行率的上升是心臟工作站市場的主要動力。根據2025年1月《心臟衰竭雜誌》發表的數據,目前美國約有670萬20歲以上的人患有心臟衰竭。預計在預測期內,這一數字將增加 70%,凸顯心血管疾病負擔日益加重。 2030年、2040年、2050年心臟衰竭衰竭發生率如下圖所示。隨著心臟衰竭發生率的上升,對心臟工作站等先進診斷和監測工具的需求也增加。

此外,根據美國心臟協會2024年心臟病和中風統計更新,心血管疾病是2021年931,578人死亡的根本原因,超過所有癌症和慢性呼吸系統疾病導致的死亡人數總合。這令人震驚的統計數據凸顯了及時診斷和有效管理心血管疾病的重要性。因此,對支持全面心血管評估和簡化臨床工作流程的心臟工作站的需求顯著成長。

此外,隨著全球心臟疾病負擔的增加,心電圖測試的數量也顯著增加。光是在美國,每年就會進行超過 1 億次 12 次導程心電圖測試,使其成為檢測心臟疾病最常用的診斷工具。此外,根據 GE 醫療集團 2023 年 2 月發表的報導,全球整體每年在急性護理和門診環境中進行超過 3 億次心電圖測試。因此,每年進行的心電圖測試超過 3 億次,預計對心臟工作站的需求將會增加,以簡化工作流程、提高診斷準確性並滿足日益成長的有效心臟護理需求。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 心臟工作站市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 心臟工作站市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

4. 心臟工作站市場-最終用途、預估及趨勢分析

  • 細分儀表板
  • 全球心臟工作站市場波動分析
  • 2018-2030年全球心臟工作站市場規模及趨勢分析(依最終用途)
  • 醫院
    • 2018-2030年醫院市場估計與預測
  • 門診手術中心
    • 2018-2030年門診手術中心市場估計與預測
  • 醫生辦公室/專科診所/辦公室檢查實驗室
    • 2018 年至 2030 年醫生辦公室/專科診所/辦公室檢測市場估計與預測
  • 專業護理機構
    • 專業護理機構市場估計與預測(2018-2030)
  • 其他
    • 2018-2030年其他市場估計與預測

5. 心臟工作站市場:按分銷管道分類的估值和趨勢分析

  • 細分儀表板
  • 全球心臟工作站市場波動分析
  • 全球心臟工作站市場規模及通路趨勢分析(2018-2030)
  • 醫療突波分佈
  • IT/CDW/VAR(增值轉售商)

6. 心臟工作站市場:區域、估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測與趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
  • 2024年主要企業市場佔有率分析
    • Koninklijke Philips NV
    • GE HealthCare
    • Baxter (Hillrom Services, Inc.)
    • AFC Industries, Inc.
    • SCHILLER AG
    • EDAN Instruments, Inc.
    • Medtronic
    • CONTEC MEDICAL SYSTEMS CO.,LTD
    • Lepu Medical Technology(Beijing)Co.,Ltd.
    • Cardioline SPA
  • 熱圖分析/企業市場分析
  • 2024年企業市場佔有率預測分析
  • 其他主要市場參與企業
Product Code: GVR-4-68040-561-0

Cardiac Workstation Market Size & Trends:

The global cardiac workstation market size was estimated at USD 363.26 million in 2024 and is projected to grow at a CAGR of 9.10% from 2025 to 2030. The cardiac workstation market is driven by the rising prevalence of cardiovascular diseases, increasing electrocardiogram (ECG) procedures, and the growing geriatric population, which is more susceptible to heart conditions. According to the data published by the Oxford University Press in November 2024, over 300 million ECGs are performed annually across the globe.

The rising incidence of cardiovascular diseases significantly drives the cardiac workstation market. According to the data published in the Journal of Cardiac Failure in January 2025, about 6.7 million individuals living in America over the age of 20 currently live with heart failure. This number is projected to increase by 70% over the forecast period, underscoring the growing burden of cardiovascular conditions. The incidence of heart failure in 2030, 2040, and 2050 is represented in the figure below. As the incidence of heart failure rises, there is a growing demand for advanced diagnostic and monitoring tools, such as cardiac workstations.

Moreover, according to the 2024 Heart Disease and Stroke Statistics Update by the American Heart Association, cardiovascular disease was the underlying cause of 931,578 deaths in the U.S. in 2021-surpassing deaths from all forms of cancer and chronic lower respiratory diseases combined. This alarming statistic highlights the critical need for timely diagnosis and efficient management of cardiovascular conditions. As a result, the demand for cardiac workstations, which support comprehensive cardiovascular assessment and streamline clinical workflows, is witnessing substantial growth.

In addition, due to the growing burden of cardioavcular diseases across the globe, the number of ECG procedures is also increasing significantly. In the U.S. alone, over 100 million 12-lead ECGs are performed annually, making it the most commonly used diagnostic tool for detecting heart disease. Also, as per the data published in GE HealthCare's article in February 2023, more than 300 million ECGs are conducted each year globally across both acute care and ambulatory settings. Thus, the extensive need and large number of ECG procedures undertaken yearly are anticipated to boost the demand for cardiac workstations to streamline workflows, improve diagnostic precision, and meet the growing demand for effective cardiac care.

Global Cardiac Workstation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global cardiac workstation market report on the basis of end-use, distribution channel, and region

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Physician Offices/ Specialty Clinics/ Office Based Labs
  • Skilled Nursing Facilities
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Medical Surge Distribution
  • IT/ CDW/ VAR-Value Added Reseller
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. End Use
    • 1.1.2. Distribution Channel
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cardiac Workstation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiac disorders
      • 3.2.1.2. Rising number of ECG procedures
      • 3.2.1.3. Introduction of innovative and advanced products
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness in some regions
      • 3.2.2.2. High treatment costs
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Improvements in public and private hospital infrastructure
      • 3.2.3.2. Growth potential in emerging economies in cardiac workstation market
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Product recalls
  • 3.3. Cardiac Workstation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Cardiac Workstation Devices: End Use Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cardiac Workstation Market Movement Analysis
  • 4.3. Global Cardiac Workstation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 4.4. Hospitals
    • 4.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Ambulatory Surgery Centers
    • 4.5.1. Ambulatory surgery centers market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Physician Offices/ Specialty Clinics/ Office Based Labs
    • 4.6.1. Physician offices/ specialty clinics/ office based labs market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Skilled Nursing Facilities
    • 4.7.1. Skilled nursing facilities market estimates and forecast 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Cardiac Workstation Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cardiac Workstation Market Movement Analysis
  • 5.3. Global Cardiac Workstation Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Medical Surge Distribution
    • 5.4.1. Medical surge distribution market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. IT/ CDW/ VAR-(Value Added Reseller)
    • 5.5.1. IT/ CDW/ VAR-(Value Added Reseller) market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Cardiac Workstation Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada market estimates and forecasts, 2018 - 2030
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. Reimbursement scenario
      • 6.4.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.4.6. Denmark
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.5.2. India
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.5.3. China
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.5.4. South Korea
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
  • 7.4. Global Key company market share analysis, 2024
    • 7.4.1. Koninklijke Philips N.V
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. GE HealthCare
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Baxter (Hillrom Services, Inc.)
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. AFC Industries, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. SCHILLER AG
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. EDAN Instruments, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Medtronic
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. CONTEC MEDICAL SYSTEMS CO.,LTD
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Lepu Medical Technology(Beijing)Co.,Ltd.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Cardioline S.P.A.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
  • 7.5. Heat Map Analysis/ Company Market Position Analysis
  • 7.6. Estimated Company Market Share Analysis, 2024
  • 7.7. List of Other Key Market Player

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America cardiac workstation market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8 Canada cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 10 Mexico cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Mexico cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 12 Europe cardiac workstation market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 UK cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 16 UK cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 Germany cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Germany cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 19 France cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 20 France cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Italy cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Italy cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Spain cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Spain cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Denmark cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Sweden cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Sweden cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Norway cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Norway cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific cardiac workstation market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 China cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 China cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 36 Japan cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Japan cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38 India cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 39 India cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 40 South Korea cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 41 South Korea cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Australia cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Australia cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 Thailand cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 Thailand cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Latin America cardiac workstation market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Latin America cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Brazil cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Brazil cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 Mexico cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Mexico cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Argentina cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Argentina cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa cardiac workstation market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 South Africa cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Africa cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 UAE cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 63 UAE cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 64 Kuwait cardiac workstation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Kuwait cardiac workstation market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Cardiac Workstation Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Global Cardiac Workstation Market, for End Use, 2018 - 2030 (USD Million)
  • Fig. 15 Global Cardiac Workstation Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 16 Global Cardiac Workstation Market, for Ambulatory Surgery Centers, 2018 - 2030 (USD Million)
  • Fig. 17 Global Cardiac Workstation Market, for Physician Offices/ Specialty Clinics/ Office Based Labs, 2018 - 2030 (USD Million)
  • Fig. 18 Global Cardiac Workstation Market, for Skilled Nursing Facilities, 2018 - 2030 (USD Million)
  • Fig. 19 Global Cardiac Workstation Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 20 Global Cardiac Workstation Market, for Distribution Channel, 2018 - 2030 (USD Million)
  • Fig. 21 Global Cardiac Workstation Market, for Medical Surge Distribution, 2018 - 2030 (USD Million)
  • Fig. 22 Global Cardiac Workstation Market, for IT/ CDW/ VAR-Value Added Reseller, 2018 - 2030 (USD Million)
  • Fig. 23 Regional Outlook, 2024 & 2030
  • Fig. 24 North America Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 26 Canada Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 30 UK Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 31 France Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 39 China Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 40 India Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 46 Argentina Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 47 Middle East and Africa Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 50 UAE Cardiac Workstation Market, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait Cardiac Workstation Market, 2018 - 2030 (USD Million)